Serina Therapeutics, Inc.

SERAMEXHealthcare● Active

$1.90

+$0.02(+1.06%)

Market Cap$20583333

P/E Ratio—

52W High$7.92

52W Low$1.22

Avg Volume3.2M

Open$1.93

Beta0.10

Insider Trades Ownership Employees

Serina Therapeutics, Inc. (SER) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · SER · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.08

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 7%Active transactions only · RSU vesting excluded93% Sell ↓

Serina Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

SER insider buying and selling by quarter

SER insider selling · SER insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.1M527K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · SER ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

SER executive sell shares · SER board member insider trading · SER insider trading SEC filing

Showing 59 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 26, 2026	LEDGER STEVEN A CEO · Director	Award	10,100	$1.93	$19K	10,100	Form 4
May 22, 2026	WILSON KAREN J Director	Purchase	10,000	$1.93	$19K	20,000	Form 4
May 21, 2026	WILSON KAREN J Director	Purchase	10,000	$1.77	$18K	10,000	Form 4
May 19, 2026	Marshall Richard Peter Director	Purchase	12,183	$1.65	$20K	12,183	Form 4
Mar 31, 2026	Bailey Gregory Director	Award	59,667	$1.94	$116K	126,910	Form 4
Mar 31, 2026	Venkatesan Jay Director	Award	7,553	$1.94	$15K	7,553	Form 4
Mar 23, 2026	Moreadith Randall Chief Scientific Officer	Option	6,500	$0.06	$390	6,500	Form 4
Mar 23, 2026	Moreadith Randall Chief Scientific Officer	Sale	6,500	$2.86	$19K	0	Form 4
Mar 19, 2026	Moreadith Randall Chief Scientific Officer	Option	39,000	$0.06	$2K	39,000	Form 4
Mar 19, 2026	Moreadith Randall Chief Scientific Officer	Sale	39,000	$2.50	$98K	0	Form 4
Feb 2, 2026	Moreadith Randall Chief Scientific Officer	Option	6,500	$0.06	$390	6,500	Form 4
Feb 2, 2026	Moreadith Randall Chief Scientific Officer	Sale	6,500	$3.03	$20K	0	Form 4
Jan 28, 2026	Moreadith Randall Chief Scientific Officer	Option	6,500	$0.06	$390	6,500	Form 4
Jan 28, 2026	Moreadith Randall Chief Scientific Officer	Sale	6,500	$3.57	$23K	0	Form 4
Jan 22, 2026	Moreadith Randall Chief Scientific Officer	Option	2,500	$0.06	$150	2,500	Form 4
Jan 22, 2026	Moreadith Randall Chief Scientific Officer	Sale	2,500	$2.95	$7K	0	Form 4
Jan 21, 2026	Moreadith Randall Chief Scientific Officer	Option	2,000	$0.06	$120	2,000	Form 4
Jan 20, 2026	Moreadith Randall Chief Scientific Officer	Sale	2,000	$3.07	$6K	0	Form 4
Jan 21, 2026	Moreadith Randall Chief Scientific Officer	Sale	2,000	$3.00	$6K	0	Form 4
Jan 13, 2026	Moreadith Randall Chief Scientific Officer	Option	5,416	$0.06	$325	5,416	Form 4
Jan 14, 2026	Moreadith Randall Chief Scientific Officer	Option	1,084	$0.06	$65	1,084	Form 4
Jan 14, 2026	Moreadith Randall Chief Scientific Officer	Sale	1,084	$2.50	$3K	0	Form 4
Jan 13, 2026	Moreadith Randall Chief Scientific Officer	Sale	5,416	$2.50	$14K	0	Form 4
Jan 8, 2026	Moreadith Randall Chief Scientific Officer	Option	13,000	$0.06	$780	13,000	Form 4
Jan 8, 2026	Moreadith Randall Chief Scientific Officer	Sale	13,000	$2.69	$35K	0	Form 4

LEDGER STEVEN A

CEO · Director

Award

Date

May 26

10,100

Price

$1.93

Value

$19K

View Form 4 on SEC.gov

WILSON KAREN J

Director

Purchase

Date

May 22

10,000

Price

$1.93

Value

$19K

View Form 4 on SEC.gov

WILSON KAREN J

Director

Purchase

Date

May 21

10,000

Price

$1.77

Value

$18K

View Form 4 on SEC.gov

Marshall Richard Peter

Director

Purchase

Date

May 19

12,183

Price

$1.65

Value

$20K

View Form 4 on SEC.gov

Bailey Gregory

Director

Award

Date

Mar 31

59,667

Price

$1.94

Value

$116K

View Form 4 on SEC.gov

Venkatesan Jay

Director

Award

Date

Mar 31

7,553

Price

$1.94

Value

$15K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Mar 23

6,500

Price

$0.06

Value

$390

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Mar 23

6,500

Price

$2.86

Value

$19K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Mar 19

39,000

Price

$0.06

Value

$2K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Mar 19

39,000

Price

$2.50

Value

$98K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Feb 2

6,500

Price

$0.06

Value

$390

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Feb 2

6,500

Price

$3.03

Value

$20K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Jan 28

6,500

Price

$0.06

Value

$390

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Jan 28

6,500

Price

$3.57

Value

$23K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Jan 22

2,500

Price

$0.06

Value

$150

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Jan 22

2,500

Price

$2.95

Value

$7K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Jan 21

2,000

Price

$0.06

Value

$120

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Jan 20

2,000

Price

$3.07

Value

$6K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Jan 21

2,000

Price

$3.00

Value

$6K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Jan 13

5,416

Price

$0.06

Value

$325

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Jan 14

1,084

Price

$0.06

Value

$65

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Jan 14

1,084

Price

$2.50

Value

$3K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Jan 13

5,416

Price

$2.50

Value

$14K

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Option

Date

Jan 8

13,000

Price

$0.06

Value

$780

View Form 4 on SEC.gov

Moreadith Randall

Chief Scientific Officer

Sale

Date

Jan 8

13,000

Price

$2.69

Value

$35K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About SER insider trading

SER insider trades

Serina Therapeutics, Inc. (SER) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Moreadith Randall (Chief Scientific Officer), WILSON KAREN J (Director), LEDGER STEVEN A (CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. SER insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Serina Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

SER insider trading · 5 questions

The insiders of Serina Therapeutics, Inc. (SER) include executives and directors such as Moreadith Randall (Chief Scientific Officer), WILSON KAREN J (Director), LEDGER STEVEN A (CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

SER board member insider tradingwho are SER insidersSER insider rosterSerina Therapeutics, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026